Cite
MLA Citation
Gulbanu Sarsenbayeva et al.. “Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.” Human vaccines & immunotherapeutics, vol. 16, no. 8, 2020, pp. 1791–1797. http://access.bl.uk/ark:/81055/vdc_100159080056.0x00000a